Electro-Acupuncture for Obese Patients with Insulin Resistance
Launched by NANYANG TECHNOLOGICAL UNIVERSITY · Sep 20, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of electro-acupuncture on obese patients who have insulin resistance, a condition where the body does not use insulin effectively. The researchers want to find out if this treatment can help improve their health. The trial will involve 60 participants who will be randomly assigned to receive either real electro-acupuncture or a placebo treatment that does not have any active effect.
To be eligible for the study, participants must be men or women aged 21 to 65 who have a body mass index (BMI) of 25 or higher and specific blood sugar levels indicating insulin resistance. However, people with diabetes, certain heart conditions, recent significant weight changes, or other serious health issues will not be able to participate. If selected, participants can expect to attend sessions where they will receive the treatment, and they will be monitored throughout the study to ensure their safety. This trial is currently not recruiting participants, but it aims to provide valuable information about alternative treatments for obesity and insulin resistance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women aged between 21 and 65 years old
- • BMI ≥ 25 kg/m2
- • HOMA-IR ≥ 2.14, (HOMA-IR = fasting insulin (ųU/mL)\* fasting glucose (mmol/L)/22.5)
- • Not receiving any other weight control measures or any medical and/or drug history in the last 3 months
- Exclusion Criteria:
- • Diabetes mellitus
- • Treating with drugs that may affect insulin sensitivity
- • Changes 10% of usual body weight in the previous 6 months weight
- • Endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc.
- • Heart diseases, including arrhythmia, heart failure, and myocardial infarction, participants with pacemakers
- • Allergy and immunology diseases
- • Bleeding tendency
- • Pregnant or lactating women
- • Impaired hepatic or renal function
- • Stroke or unable to exercise
About Nanyang Technological University
Nanyang Technological University (NTU) is a leading research-intensive institution located in Singapore, renowned for its commitment to advancing knowledge and innovation across various fields, including healthcare and biomedical sciences. As a clinical trial sponsor, NTU leverages its cutting-edge research capabilities and interdisciplinary expertise to facilitate groundbreaking clinical studies aimed at improving patient outcomes and enhancing medical practices. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to ensure rigorous scientific methodologies and ethical standards are upheld throughout the research process. NTU's focus on translating research findings into real-world applications positions it at the forefront of medical advancements and contributes significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported